A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
Part of paid clinical trials in Encinitas, California.
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Study ID
- NCT07733947
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Subcutaneous Fat
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CBL-514 Injection — DRUGProvided as a ready for use injectable CBL-514 solution
- 0.9 % sodium chloride — DRUGInjectable 0.9% Sodium Chloride solution as placebo
Study Details
A Phase 3b, Multicenter, Two stage, Double-blind, Long term Follow up and Open-label Extension Study of Participants Who have Completed the CBL-0301 or CBL-0302 Study for Reducing Abdominal Subcutaneous Fat (Stage 1)
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Dec 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Aug 31, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CBL-514 injectionNo study drug will be administered in Stage 1. Eligible participants who received prior treatment with CBL-514 in the parent studies will be included.
- Placebo Comparator: Injectable 0.9% Sodium Chloride solutionNo study drug will be administered in Stage 1. Eligible participants who received prior treatment with Placebo in the parent studies will be included.
Primary Outcome Measure
Percentage of participants with at least 1 TEAE [ Time Frame: 6,9, and 12 months after last treatment of parent studies ]
Central Contacts
- NT Tan+886-2-26971355
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Investigational site 1 | Encinitas | California | 92024 | - |
Find similar trials in Encinitas, CA
By research site
Related Studies
- A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous FatPHASE3 · Not Yet Recruiting · Caliway Biopharmaceuticals Co., Ltd. · Encinitas, California
- A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )PHASE3 · Not Yet Recruiting · Caliway Biopharmaceuticals Co., Ltd. · Encinitas, California